Difference between revisions of "File:Fig7 Maury FrontDigHlth2021 3.jpg"

From LIMSWiki
Jump to navigationJump to search
(Added summary.)
 
Line 1: Line 1:
==Summary==
==Summary==
{{Information
{{Information
|Description='''Figure 7.''' SARS-CoV-2 RT-PCR systems introduced in our laboratory. RT-PCR for the detection of SARS-CoV-2 from clinical specimens were achieved using several instruments introduced in our laboratory. The in-house molecular diagnostic platform (Molecular Dx platform) and the cobas SARS-CoV-2 instrument are two high-throughput RT-PCR systems, while the Xpert Xpress SARS-CoV-2 assay (Cepheid, CA, USA) and the cobas SARS-CoV-2-Influenza A/B test are rapid RT-PCR systems used for emergencies, adapted from Opota ''et al.'' [6] and Marquis ''et al.'' [8].
|Description='''Figure 7.''' SARS-CoV-2 RT-PCR systems introduced in our laboratory. RT-PCR for the detection of SARS-CoV-2 from clinical specimens were achieved using several instruments introduced in our laboratory. The in-house molecular diagnostic platform (Molecular Dx platform) and the cobas SARS-CoV-2 instrument are two high-throughput RT-PCR systems, while the Xpert Xpress SARS-CoV-2 assay (Cepheid, CA, USA) and the cobas SARS-CoV-2-Influenza A/B test are rapid RT-PCR systems used for emergencies, adapted from Opota ''et al.'' and Marquis ''et al.''
|Source={{cite journal |title=An automated dashboard to improve laboratory COVID-19 diagnostics management |journal=Frontiers in Digital Health |author=Maury, E.; Boldi, M.-O.; Greub, G.; Chavez, V.; Jaton, K.; Opota, O. |volume=3 |at=773986 |year=2021 |doi=10.3389/fdgth.2021.773986}}
|Source={{cite journal |title=An automated dashboard to improve laboratory COVID-19 diagnostics management |journal=Frontiers in Digital Health |author=Maury, E.; Boldi, M.-O.; Greub, G.; Chavez, V.; Jaton, K.; Opota, O. |volume=3 |at=773986 |year=2021 |doi=10.3389/fdgth.2021.773986}}
|Author=Maury, E.; Boldi, M.-O.; Greub, G.; Chavez, V.; Jaton, K.; Opota, O.
|Author=Maury, E.; Boldi, M.-O.; Greub, G.; Chavez, V.; Jaton, K.; Opota, O.

Latest revision as of 21:58, 17 February 2022

Summary

Description

Figure 7. SARS-CoV-2 RT-PCR systems introduced in our laboratory. RT-PCR for the detection of SARS-CoV-2 from clinical specimens were achieved using several instruments introduced in our laboratory. The in-house molecular diagnostic platform (Molecular Dx platform) and the cobas SARS-CoV-2 instrument are two high-throughput RT-PCR systems, while the Xpert Xpress SARS-CoV-2 assay (Cepheid, CA, USA) and the cobas SARS-CoV-2-Influenza A/B test are rapid RT-PCR systems used for emergencies, adapted from Opota et al. and Marquis et al.

Source

Maury, E.; Boldi, M.-O.; Greub, G.; Chavez, V.; Jaton, K.; Opota, O. (2021). "An automated dashboard to improve laboratory COVID-19 diagnostics management". Frontiers in Digital Health 3: 773986. doi:10.3389/fdgth.2021.773986. 

Date

2021

Author

Maury, E.; Boldi, M.-O.; Greub, G.; Chavez, V.; Jaton, K.; Opota, O.

Permission
(Reusing this file)

Creative Commons Attribution 4.0 International

Other versions


Licensing

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current21:56, 17 February 2022Thumbnail for version as of 21:56, 17 February 20221,084 × 574 (209 KB)Shawndouglas (talk | contribs)

Metadata